ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 660 filers reported holding ASTRAZENECA PLC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $539,281 | +15.7% | 7,954 | -6.5% | 0.00% | 0.0% |
| Q3 2022 | $466,000 | -6.0% | 8,503 | +13.2% | 0.00% | 0.0% |
| Q2 2022 | $496,000 | -0.4% | 7,512 | +0.1% | 0.00% | +50.0% |
| Q1 2022 | $498,000 | -0.4% | 7,502 | -15.0% | 0.00% | 0.0% |
| Q4 2021 | $500,000 | +8.2% | 8,828 | +14.8% | 0.00% | 0.0% |
| Q3 2021 | $462,000 | -3.3% | 7,687 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $478,000 | +2.4% | 7,980 | -15.0% | 0.00% | -33.3% |
| Q1 2021 | $467,000 | -16.2% | 9,387 | -15.8% | 0.00% | -25.0% |
| Q4 2020 | $557,000 | -6.9% | 11,149 | +2.2% | 0.00% | -20.0% |
| Q3 2020 | $598,000 | +6.2% | 10,907 | +2.4% | 0.01% | 0.0% |
| Q2 2020 | $563,000 | +6.4% | 10,647 | -10.1% | 0.01% | 0.0% |
| Q1 2020 | $529,000 | +22.7% | 11,843 | +37.1% | 0.01% | +25.0% |
| Q4 2019 | $431,000 | +46.1% | 8,637 | +30.1% | 0.00% | +33.3% |
| Q3 2019 | $295,000 | – | 6,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |